Log in to save to my catalogue

Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach

Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2686429451

Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach

About this item

Full title

Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2022-07

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

Objective: Pharmacokinetics (PK) of a drug drive its exposure, efficacy, and tolerability. A thorough preclinical PK assessment of antiseizure medications (ASMs) is therefore essential to evaluate the clinical potential. We tested protection against evoked seizures of prototype ASMs in conjunction with analysis of plasma and brain PK as a proof-of-...

Alternative Titles

Full title

Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2686429451

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2686429451

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2022.07.07.499055